Medtronic Agrees To Settle Infuse Shareholder Class For $85M, Denies Liability

Medtronic Agrees To Settle Infuse Shareholder Class For $85M, Denies Liability

MINNEAPOLIS - Medtronic Inc. on March 30 said in a press release that it has agreed in principle to settle a stockholder class action involving its Infuse Bone Graft product for $85 million (Minneapolis Firefighters' Relief Association, et al. v. Medtronic, Inc., No. 08-6324, D. Minn.).

Find full version on lexis Advance®
Access this news story on lexis.com®